NewGenIvf Group Limited Class A ordinary shares (NIVF)
$0.4872▼ −29.65%
Close Nov 5, 2026 · split-adjusted
Nov 4, 2026$0.69▼ 99.99% in range
Nov 4, 2025Low $0.69 · High $10955.52Nov 4, 2026
What changed · written from our data
As of Nov 5, 2026
NewGenIvf Group Limited closed at $0.49 on Nov 5, down 29.65%, within 0.0% of its 52-week closing low. Volume of 221.8K shares was 0.02× its 20-day average (below normal).
Split-adjusted performance: -85.6% over one month, -99.9% over six months, -100.0% over one year.
Short interest was 2.5M shares at the Oct 15 settlement, up 3427.1% from the prior report (41.7% of float, 1.0 days to cover).
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services.
What is NIVF's market cap?
$4.82M, based on the Nov 5 close of $0.49.
Does NewGenIvf Group Limited pay a dividend?
No regular cash dividend has been paid in the last year.
How much of NIVF is sold short?
2.5M shares, 41.7% of float, as of Oct 15, 2026.
About NewGenIvf Group Limited
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology